ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

DRMA Stock Ownership Breakdown

NASDAQ : DRMA

Dermata Therapeutics, Inc.

$1.18

-0.04-327.90%

At Close 4:00 PM

66.29

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

DRMA Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares6.21

Short Percent Of Float6.28

Shares Outstanding5.36M

Shares Float1.30M

Shares Short93.74K

Short Ratio0.52

6.28%

Short % of Float

6.21%

Short % of Shares Outstanding

Market Insider DRMA

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.84% Percentage of Shares held by All Insiders

0.66% Percentage of Shares held by All Institutions

0.67% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 0.66% of DRMA shares are held by financial institutions. TUDOR INVESTMENT CORP ET AL is the top corporate investor, holding 0 shares valued at -. A 0% stake in Dermata Therapeutics, Inc. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2023	TUDOR INVESTMENT CORP ET AL	0%	-	-10.21K	-10,000.00%
Mar 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0%	-	-26.67K	-10,000.00%
Mar 31, 2023	TWO SIGMA SECURITIES, LLC	0%	-	-12.43K	-10,000.00%
Mar 31, 2023	RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0%	-	-141.76K	-10,000.00%
Mar 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	-	-4.69K	-10,000.00%
Mar 31, 2023	FAS WEALTH PARTNERS, INC.	0%	-	-12.7K	-10,000.00%
Mar 31, 2023	UBS GROUP AG	0%	-	-37.31K	-10,000.00%
Mar 31, 2023	SAGE CAPITAL ADVISORS,LLC	0%	-	-12K	-10,000.00%
Mar 31, 2023	HC ADVISORS, LLC	0%	-	-10K	-10,000.00%
Mar 31, 2023	WELLS FARGO & COMPANY/MN	0%	-	-24.44K	-10,000.00%
Mar 31, 2023	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	-	0	0
Mar 31, 2023	MORGAN STANLEY	0%	-	-562	-10,000.00%

DRMA Insiders

Among the DRMA insiders holding of 0.84% of the stake in company, PROEHL GERALD T, President, CEO and Chairman, holds the largest shares of 59.51K. HALE DAVID F, director, is the second largest DRMA insider with ownership of 35.71K shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
PROEHL GERALD T	President, CEO and Chairman	59.51K
HALE DAVID F	director	35.71K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 23, 2021	PROEHL GERALD T	PURCHASE	2.40	20K	48K	59.51K
Aug 17, 2021	HALE DAVID F	PURCHASE	7.00	35.71K	250K	35.71K
Aug 16, 2021	PROEHL GERALD T	PURCHASE	4.96	10K	49.63K	10K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter